Janney Montgomery Scott’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-633
Closed -$247K 2247
2021
Q1
$247K Buy
+633
New +$312K ﹤0.01% 1957
2020
Q4
Sell
-850
Closed -$594K 2223
2020
Q3
$594K Buy
850
+363
+75% +$283K ﹤0.01% 1350
2020
Q2
$385K Buy
+487
New +$367K ﹤0.01% 1492

Other funds holding BLUE

Janney Montgomery Scott's BLUE Position: Q2 2021 in Review

Janney Montgomery Scott sold out of bluebird bio (BLUE) in Q2 2021, closing a stake of 633 shares — an estimated $247K sold.

Janney Montgomery Scott first reported a position in BLUE in Q2 2020 and held it in 3 quarters. The position peaked at $594K in Q3 2020. 232 funds tracked by Wall St. Rank hold BLUE as of Q2 2021.

  • Janney Montgomery Scott reported no remaining bluebird bio position as of Q2 2021 after selling out during the quarter.
  • Janney Montgomery Scott sold 633 bluebird bio shares in Q2 2021, an estimated $247K.
  • Janney Montgomery Scott first reported a position in bluebird bio in Q2 2020 and held it in 3 quarters.
  • Janney Montgomery Scott's bluebird bio position peaked at $594K in Q3 2020.
  • 232 funds tracked by Wall St. Rank held bluebird bio as of Q2 2021.

Based on Janney Montgomery Scott's 13F filing for Q2 2021, filed 26 Jul 2021.